Related Experiment Videos
Mitochondrial defect in Huntington's disease caudate nucleus
1Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, London, United Kingdom.
Insights
Huntington's disease (HD) involves mitochondrial defects in the brain, specifically in the caudate nucleus, impacting energy metabolism. Platelets showed no such mitochondrial dysfunction in patients with Huntington's disease.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Genetics
Background:
- Huntington's disease (HD) is a neurodegenerative disorder with an identified genetic defect, but the precise pathogenetic mechanisms remain unclear.
- Evidence suggests impaired energy metabolism and excitotoxicity contribute to selective neuronal death in HD.
- Toxin models mimicking HD involve inhibitors of succinate dehydrogenase (complex II), a key component of the mitochondrial respiratory chain.
Purpose of the Study:
- To investigate mitochondrial respiratory chain function in brain tissue and blood cells of Huntington's disease patients.
- To compare mitochondrial function in HD patients with established toxin models of the disease.
Main Methods:
- Analysis of mitochondrial respiratory chain complex activity in the caudate nucleus (n=10) and platelets (n=11) from HD patients.
- Assessment of complexes II, III, and IV activities.
Main Results:
- Significant defects in complex II (53-59%) and complex III (53-59%) were observed in the caudate nucleus of HD patients (p < 0.0005).
- A notable deficiency in complex IV activity (32-38%) was also demonstrated in the caudate nucleus (p < 0.01).
- No mitochondrial respiratory chain deficiencies were detected in platelets from HD patients.
Conclusions:
- The study identifies severe mitochondrial respiratory chain defects in the caudate nucleus of Huntington's disease patients.
- These findings in HD brain tissue mirror those seen in toxin-induced HD models, supporting the role of energy metabolism dysfunction.
- The direct link between the huntingtin protein and the observed mitochondrial defect requires further investigation.
Abstract:
Although the Huntington's disease (HD) gene defect has been identified, the structure and function of the abnormal gene product and the pathogenetic mechanisms involved in producing death of selective neuronal populations are not understood. Indirect evidence from several sources indicates that a defect of energy metabolism and consequent excitotoxicity are involved in HD. Toxin models of HD may be induced by 3-nitropropionic acid or malonate, both inhibitors of succinate dehydrogenase, complex II of the mitochondrial respiratory chain. We analyzed mitochondrial respiratory chain function in the caudate nucleus (n = 10) and platelets (n = 11) from patients with HD. In the caudate nucleus, severe defects of complexes II and III (53-59%, p < 0.0005) and a 32-38% (p < 0.01) deficiency of complex IV activity were demonstrated. No deficiencies were found in platelet mitochondrial function. The mitochondrial defect identified in HD caudate parallels that induced by HD neurotoxin models and further supports the role of abnormal energy metabolism in HD. The relationship of the mitochondrial defect to the role of huntingtin is not known.